Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057105281047v1
10/7/667    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Brenk, R.
Right arrow Articles by Shoichet, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brenk, R.
Right arrow Articles by Shoichet, B. K.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Here Be Dragons: Docking and Screening in an Uncharted Region of Chemical Space

Ruth Brenk

John J. Irwin

Brian K. Shoichet

University of California, San Francisco, Department of Pharmaceutical Chemistry, 1700 4th Street, San Francisco, CA 94143-2550shoichet{at}cgl.ucsf.edu

To compare virtual and high-throughput screening in an unbiased way, 50,000 compounds were docked into the 3-dimensional structure of dihydrofolate reductase prospectively, and the results were compared to a subsequent experimental screening of the same library. Undertaking these calculations demanded careful database curation and control calculations with annotated inhibitors. These ultimately led to a ranked list of more likely and less likely inhibitors and to the prediction that relatively few inhibitors would be found in the empirical screen. The latter prediction turned out to be correct, with arguably no validated inhibitors found experimentally. Subsequent retesting of high-scoring docked molecules may have found 2 true inhibitors, although this remains uncertain due to experimental ambiguities. The implications of this study for screening campaigns are considered.

Key Words: high-throughput screening • HTS • virtual screening • molecular docking • database preparation

This version was published on October 1, 2005

Journal of Biomolecular Screening, Vol. 10, No. 7, 667-674 (2005)
DOI: 10.1177/1087057105281047


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
P. T. Lang, I. D. Kuntz, G. M. Maggiora, and J. Bajorath
Evaluating the High-Throughput Screening Computations
J Biomol Screen, October 1, 2005; 10(7): 649 - 652.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
N. H. Elowe, J. E. Blanchard, J. D. Cechetto, and E. D. Brown
Experimental Screening of Dihydrofolate Reductase Yields a "Test Set" of 50,000 Small Molecules for a Computational Data-Mining and Docking Competition
J Biomol Screen, October 1, 2005; 10(7): 653 - 657.
[Abstract] [PDF]